$92.86
2.062.26%
Last update: Nov 3, 2:49 PM
Kiniksa Pharmaceuticals International PLC (KNSA) Stock Price, Quote, News & History
KNSANASDAQ
U.S. stocks mostly rose Tuesday: S&P 500 +0.5%, Nasdaq +1.1%, while Dow slipped. Oil fell 1.5%; Corning beat Q3 estimates.
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kiniksa Pharmaceuticals has a consensus price target of $87.30.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $92.855 last updated November 3, 2026 at 2:49 PM EST.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
